Sven D. Koch

CureVac (Germany) — Germany

Immunology and Microbiology · Life Sciences

23h-index3.3kcitations78works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(27), Cancer Immunotherapy and Biomarkers(18), Immune Cell Function and Interaction(16), T-cell and B-cell Immunology(15), RNA Interference and Gene Delivery(12)

Publications76 total

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
Journal for ImmunoTherapy of Cancer·2025· 4 citedOpen Access
CTIM-08. FIRST IN HUMAN STUDY OF THE MRNA-BASED CANCER VACCINE CVGBM IN PATIENTS (PTS) WITH NEWLY-DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA (GBM): FIRST RESULTS FROM THE DOSE ESCALATION PHASE
Neuro-Oncology·2024Open Access
697 Preliminary immunogenicity results from the dose escalation phase of a first-in-human study of the mRNA-based cancer vaccine CVGBM in patients with newly diagnosed MGMT-unmethylated glioblastoma
Regular and Young Investigator Award Abstracts·2024Open Access
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study
Human Vaccines & Immunotherapeutics·2024· 4 citedOpen Access
440O First in human study of the mRNA-based cancer vaccine CVGBM in patients (pts) with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma (GBM): First results from the dose escalation phase
Annals of Oncology·2024· 3 cited
Phase 1 dose-finding study to evaluate safety and tolerability of CVGBM in patients with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma.
Journal of Clinical Oncology·2024· 4 cited
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity
Vaccines·2024· 3 citedOpen Access
P06.09.B TRIAL IN PROGRESS: PHASE 1 DOSE-FINDING STUDY TO EVALUATE SAFETY AND TOLERABILITY OF CVGBM IN PATIENTS WITH NEWLY DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA
Neuro-Oncology·2023Open Access
Corrigendum to “Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study” [Vaccine: X 11 (2022) 100189]
Vaccine X·2023· 2 citedOpen Access
Data from Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
2023Open Access
Supplementary Figure Legend from Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
2023Open Access
Supplementary Figure 1 from Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
2023Open Access
Supplementary Figure Legend from Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
2023Open Access
Supplementary Figure 1 from Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
2023Open Access
Data from Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
2023Open Access
Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study
Vaccine X·2022· 19 citedOpen Access
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant
Vaccines·2022· 10 citedOpen Access
Third dose of COVID-19 vaccine, CVnCoV, increased neutralizing activity against SARS-CoV-2 wild-type and Delta variant
2022· 3 citedOpen Access
KI-unterstützte Holzartenbestimmung in Hamburg
OpenAgrar·2021
OC-0479 Towards CBCT-guided online adaptive radiotherapy for prostate cancer patients
Radiotherapy and Oncology·2021
page 1 of 4Next →

Frequent Co-authors

Ulrike Gnad-Vogt(13), Graham Pawelec(13), Mariola Fotin‐Mleczek(10), Karl‐Josef Kallen(10), Birgit Scheel(10), Henoch S. Hong(9), Cécile Gouttefangeas(7), Alfred Zippelius(7), Gianluca Quintini(7), Olaf‐Oliver Wolz(7), Sarah-Katharina Kays(6), Philipp von Eisenhart-Rothe(6), Lidia Oostvogels(6), Martin Sebastian(5), Andreas Schröder(5), Ineke J. M. ten Berge(5), Helga Junker(5), Philipp Mann(5), Regina Heidenreich(4), Richard Cathomas(4)